XHKG
1388
Market cap12mUSD
Oct 06, Last price
0.24HKD
1Q
-14.55%
Jan 2017
-93.38%
IPO
-95.56%
Name
Embry Holdings Ltd
Chart & performance
P/E
—
P/S
0.08
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-6.65%
Revenues
1.17b
+1.51%
Net income
-253m
L-32.20%
CFO
-27m
L-72.48%
Dividend
Sep 13, 20210.02 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Embry Holdings Limited operates as an investment holding company primarily focused on the entire lifecycle of women's intimate apparel, encompassing design, research, development, manufacturing, and distribution. Its product offerings include brassieres, panties, swimwear, and sleepwear, marketed under a portfolio of established brands such as EMBRY FORM, FANDECIE, COMFIT, E-BRA, IVU, IADORE, and LIZA CHENG. Beyond its core apparel business, the company also manages a collection of trademarks and holds property investments. As of December 31, 2021, it maintained a substantial retail network of 1,251 points of sale, consisting of 1,049 concessionary counters and 202 standalone stores, spread across Mainland China, Hong Kong, and Macau. An online retail platform complements its physical presence. Founded in 1975 and headquartered in Kwai Chung, Hong Kong, Embry Holdings Limited is a subsidiary of Harmonious World Limited.
Key people
Pik Ho Cheng
Chief Executive Officer, Executive Director
King Yeung Chung
Compliance Officer · since 2021
Yuk Ying Law
Group Financial Controller · since 2019
Cheng Chuen Chuen
Executive Director; Assistant General Manager - Research and Development of Embry China Garments Limited · since 2017
Qun Lu
Executive Director; Assistant General Manager - Strategic Management of Embry China Garments Limited, General Manager of Embry Shandong Garments Limited · since 2015
Ming Chu Ngok
Executive Chairman of the Board · since 2022
Company Secretary · since 2013
Chi On Chan
Non-Executive Independent Director · since 2023
Independent Non-Executive Director · since 2006
Tien-Sheng Lee
Independent Non-Executive Director · since 2006
Independent Non-Executive Director · since 2006
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||